Back to mobile site

UPDATE: Stifel Starts AbCellera Biologics (ABCL) at Buy

January 5, 2021 5:08 AM EST Send to a Friend
(Updated - January 5, 2021 5:37 AM EST)

(updating comment)Stifel initiates coverage on AbCellera Biologics (NASDAQ: ABCL) with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login